DocMorris AG (CH:DOCM)
:DOCM
Want to see CH:DOCM full AI Analyst Report?
DOCM Stock Chart & Stats
CHF6.61
CHF0.36(1.86%)
At close: 4:00 PM EST
CHF6.61
CHF0.36(1.86%)
Day’s Range― - ―
52-Week RangeCHF3.92 - CHF12.26
Previous CloseN/A
Volume45.75K
Average Volume (3M)342.18K
Market Cap
CHF340.78M
Enterprise ValueCHF508.94M
Total Cash (Recent Filing)CHF149.92M
Total Debt (Recent Filing)CHF288.64M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding51,617,825
10 Day Avg. Volume377,518
30 Day Avg. Volume342,178
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.75
Price to Sales (P/S)0.27
P/FCF Ratio-3.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF6.09Price Target Upside-7.87% Downside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)-1.78
Revenue Forecast (FY)CHF1.21B
Bulls Say, Bears Say
Bulls Say
Competitive PositioningPerformance versus a key peer shows improved market traction, suggesting the company is gaining share where the peer is experiencing a slowdown.
German Market RecoveryRebound in German over-the-counter demand after a balance sheet recapitalisation reflects effective marketing and contributes to regional sales strength.
Revenue MomentumRevenue growth is tracking toward the upper end of the company's full-year target range, supported by solid non-prescription sales and stronger marketing execution.
Bears Say
Capital DependenceMajor external capital injections during a transitory phase indicate continued reliance on outside funding, which could pressure financial flexibility or dilute existing shareholders.
Prescription Sales ShortfallPrescription sales continue to lag analyst expectations, creating headwinds for revenue growth and investor confidence.
Profitability PressureEBITDA is still expected to remain negative, keeping profitability under pressure and limiting near-term upside for the stock.
DOCM FAQ
What was DocMorris AG’s price range in the past 12 months?
DocMorris AG lowest stock price was CHF3.92 and its highest was CHF12.26 in the past 12 months.
What is DocMorris AG’s market cap?
DocMorris AG’s market cap is CHF340.78M.
When is DocMorris AG’s upcoming earnings report date?
DocMorris AG’s upcoming earnings report date is Aug 19, 2026 which is in 113 days.
How were DocMorris AG’s earnings last quarter?
Currently, no data Available
Is DocMorris AG overvalued?
According to Wall Street analysts DocMorris AG’s price is currently Overvalued.
Does DocMorris AG pay dividends?
DocMorris AG does not currently pay dividends.
What is DocMorris AG’s EPS estimate?
DocMorris AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DocMorris AG have?
DocMorris AG has 51,617,825 shares outstanding.
What happened to DocMorris AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of DocMorris AG?
Currently, no hedge funds are holding shares in CH:DOCM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DocMorris AG
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.
DOCM Stock 12 Month Forecast
Average Price Target
CHF6.09
▼(-7.87% Downside)
Technical Analysis
Idorsia Ltd
―
Santhera Pharmaceuticals Holding
―
Galenica AG
―
Galderma Group AG
―
medmix AG
―
Options Prices
Currently, No data available
---